Observational studyEuropean journal of pediatrics2025
Phototherapy modifies hematologic markers without inducing inflammation in neonates: a retrospective observational study.
Observational study in European journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Phototherapy is the standard treatment for neonatal hyperbilirubinemia. However, its impact on hematologic indices related to oxidative stress and systemic inflammation, particularly in preterm infants, remains insufficiently understood. In this retrospective observational study, 96 neonates who received phototherapy were evaluated. Hematologic ratios including red cell distribution width to platelet count (RDW/PLT), RDW to lymphocyte count (RDW/LF), and platelet distribution width to plateletcrit (PDW/PCT) were analyzed. Systemic inflammatory markers such as neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic inflammatory index (SI), systemic immune inflammation index (SIRI), and pan-inflammatory value (PIV) were also compared before and after treatment using Wilcoxon signed-rank tests. Phototherapy was associated with an increase in RDW/PLT from a median of 0.11 to 0.14 (p = 0.0007, 95% CI 0.02 to 0.05) and in RDW/LF from 2.98 to 3.62 (p = 0.0005, 95% CI 0.50 to 0.80), as well as a decrease in PDW/PCT from 42.1 to 36.4 (p = 0.0001, 95% CI - 8.0 to - 4.5). No significant changes were observed in systemic inflammatory markers (p greater than 0.05 for all). Conclusion: Phototherapy induces localized hematologic changes that may reflect oxidative activity, without provoking systemic inflammation. RDW/PLT and RDW/LF may serve as accessible indicators of oxidative response. These findings support the hematologic safety of phototherapy in term and near-term neonates, while further research is needed in extremely preterm infants due to their increased susceptibility. What is Known: • Phototherapy is an effective and widely used treatment for neonatal jaundice • Experimental studies suggest that it may influence oxidative stress pathways What is New: • This study demonstrates that phototherapy alters RDW-based hematologic ratios without activating systemic inflammation • RDW/PLT may serve as a practical early marker of oxidative stress response in neonates, reinforcing the safety of phototherapy while raising questions for preterm care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.